sexual disorders and gender identity Flashcards
2 neurological pathways involved in the sexual response cycle
Central reward – dopamine and mesolimbic
Peripheral SNS(somatic nervous sys.) mediation – hypogastric plexus
ALL DSM-5 sexual dysfunctions must ….
symptoms cause sig. distress
persist for min of 6 months
and disturb an aspect of the sexual response cycle
not better explained by anything else
delayed ejaculation
treatment
delay or absence of ejaculation on most partnered sexual activity
a. Treat: behavioral interventions to minimize performance anxiety or drugs (cyproheptadine)
erectile disorder
at least 1 of the 3:
- -hard to obtain an erection
- -hard maintaining erection until completion
- -decrease in erectile rigidity
a. Risk factors: old age, diabetes, vascular disease, smoking, hypercholesterolemia
treatment for erectile disorder
testosterone for hypogonadism
bromocriptine for hyperprolactinemia
psychotherapy
penile prosthetic
intracavernosal injections – papaverine, phenoxybenzamine, PGE1 (alprostadil)
oral therapy – sildenafil (4 hr halflife), vardenafil (4-6 hr), tadalafil (36 hrs)
female orgasmic disorder
marked delay, absence or reduced intensity of orgasm
Female Sexual Interest/Arousal Disorder
lack of or reduced interest or arousal with atleast 3 of these signs:
i. Absent/reduced interest
ii. Absent/reduced sexual/erotic thoughts
iii. No/reduced initiation of sexual activity; typically unreceptive to attempts
iv. Absent/reduced excitement/pleasure in sexual encounters
v. Absent/reduced arousal in response to sexual cues
vi. Absent or reduced genital/nongenital sensations during sex
Male Hypoactive Sexual Desire Disorder
deficient/absent sexual/erotic thoughts and desires
judgement of deficiency is made by the clinician
Premature (early) Ejaculation
ejaculation within 1 minute following vaginal penetration and before wished
a. Mild: 30 sec – 1 min after penetration
b. Mod: 15-30 sec
c. Severe: prior to/at start of – 15 sec
treatment for early ejaculation
behavioral (start-stop/squeeze) and drugs (SSRIs/clomipramine)
Genito-Pelvic Pain/Penetration disorder
Persistent or recurrent difficulties with one or more:
i. Vaginal Penetration During Intercourse
ii. Marked pain during intercourse on penetration
iii. Marked fear or anxiety of pain in anticipation of, during, or as a result of vaginal penetration
Substance/Medication Induced Sexual Dysfunction
- a clinically significant sexual dysfunction
i. Symptoms developed during/soon after substance intoxication, withdrawal, or medication
ii. The involved substance is capable of producing the symptoms
b. Not better explained and Does not occur exclusively during delirium
Paraphilias
- Paraphilias: recurrent, intense sexual arousal, fantasies, and urges involving anomalous sexual activity
- Paraphilic Disorders: the above, plus acting on urges, resulting in distress or impairment in functioning
drug used to decrease obsessive intrusive sexual fantasies?
SSRIs or naltrexone
sexual identity
gender identity
gender role
- Sexual identity – ones biological sex or ones’ sexual preference
- Gender identity – ones’ subjective sense of maleness or femaleness
- Gender role- the behaviors an individual engages in that identify as male/female